Global Cell Therapy Technologies Market (2022 to 2031) - Featuring Thermo Fisher Scientific, Merck, MaxCyte and Lonza Group Among Others


Dublin, June 24, 2022 (GLOBE NEWSWIRE) -- The "Cell Therapy Technologies Global Market Report 2022, By Product, By Cell Type, By Process, By End User" report has been added to's offering.

This report provides strategists, marketers and senior management with the critical information they need to assess the global cell therapy technologies market.

The report gives a guide to the cell therapy technologies market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis


Where is the largest and fastest growing market for the cell therapy technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cell Therapy Technologies market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

  • It traces the market's historic and forecast market growth by geography.
  • It places the market within the context of the wider cell therapy technologies market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies.
  • Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The cell therapy technologies market section of the report gives context.
  • It compares the cell therapy technologies market with other segments of the cell therapy technologies market by size and growth, historic and forecast.
  • It analyses GDP proportion, expenditure per capita, cell therapy technologies indicators comparison.

Major players in the cell therapy technologies market are Thermo Fisher Scientific, Merck, MaxCyte, Lonza Group, Sartorius, Terumo BCT, Fresenius Medical Care AG & Co. KGaA, Avantor Inc., Miltenyi Biotec, STEMCELL Technologies Inc., Beckman Coulter, Danaher, Becton Dickinson and Company and GE Healthcare.

The global cell therapy technologies market is expected to grow from $2.96 billion in 2021 to $3.52 billion in 2022 at a compound annual growth rate (CAGR) of 19.0%. The growth is mainly due to an increase in investments in cell therapies and the growth in research and development for cell therapy. The market is expected to reach $6.35 billion in 2026 at a CAGR of 15.9%.

The cell therapy technologies market consists of sales of cell therapy technologies that are medicinal solutions used for developing and improving cell therapy, such as cell processing, cell banking, and point-of-care technologies. Cell therapy is a type of treatment used to inject active cells into the body of a patient for treating some disorders. This therapy seeks to treat diseases by altering certain sets of cells. In this technique, cells, which originate from the patient or a donor are modified outside the body and then injected into the patient.

The main types of products in cell therapy technologies are consumables, equipment, systems & software and is applied on the different type of cells including t-cells, stem cells, and other cells. Stem cells are special human cells that can become almost any type of cell in the human body. This can range from brain cells to muscle cells and is also used to fix damaged tissues. The different processes include cell processing, cell preservation, distribution, and handling, process monitoring and quality control and used in various sectors such as life science companies, research institutes.

Increasing investments by the government in cell-based research contributed to the growth of the global cell therapy technologies market. Governments are increasingly investing in research activities for developing therapies for diseases such as cancer, cardiovascular disease (CVD), and others. For instance, in November 2019, the Australian government released $150 million, over 10 years, for The Stem Cell Therapies Mission. The funding was obtained by Medical Research Future Fund (MRFF), to support Australian researchers to deliver new therapies.

Moreover, in August 2019, Newcastle University spin-out Atelerix, pioneers in the storage and transport of cells at room temperature, were awarded a grant of £267,000 ($292,087) from Innovate UK, with collaborators Rexgenero and the cell and gene therapy catapult. Thus, the upsurge in government investments in cell-based research boosted the demand for the cell therapy technologies market in the historic period.

High costs associated with cell therapy is expected to restrain the market in the forecast period. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective therapies for cancer has influenced the health conditions of the population and has led to a low average life expectancy.

For example, cell therapies, especially gene-editing cell therapies such as CAR-T therapy highly expensive. The two first CAR T-cell therapies, Kymriah and Yescarta, have been given price tags of $475,000 and $373,000 respectively, in the USA, with similar pricing in Europe. Thus, the high cost of cell therapy is restraining the growth of the market.

Strategic collaborations and partnerships between the industry players are gaining popularity in the cell therapy technologies market. Major companies are collaborating and partnering with other companies to developing new technologies in cell therapy areas for the treatment of a variety of diseases.

North America was the largest region in the cell therapy technologies market in 2021. Asia Pacific is predicted to record fastest growth over the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell therapy technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

Key Topics Covered:

1. Executive Summary

2. Cell Therapy Technologies Market Characteristics

3. Cell Therapy Technologies Market Size And Growth
3.1. Global Cell Therapy Technologies Historic Market, 2016 - 2021, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Cell Therapy Technologies Forecast Market, 2021-2026F, 2031F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Cell Therapy Technologies Market Segmentation
4.1. Global Cell Therapy Technologies Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Consumables
  • Equipment
  • Systems & Software

4.2. Global Cell Therapy Technologies Market, Segmentation By Cell Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • T-cells
  • Stem Cells
  • Other Cells

4.3. Global Cell Therapy Technologies Market, Segmentation By Process, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Cell Processing
  • Cell Preservation, Distribution, and Handling
  • Process Monitoring and Quality Control

4.4. Global Cell Therapy Technologies Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Life Science Companies
  • Research Institutes

5. Cell Therapy Technologies Market Regional And Country Analysis
5.1. Global Cell Therapy Technologies Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
5.2. Global Cell Therapy Technologies Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

For more information about this report visit


Global Cell Therapy Technologies Market